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2Abstract
The apolipoprotein E gene (APOE) polymorphism genotyping has an allegedly 
important predictive value for coronary heart disorders and Alzheimer disease. We 
developed a simple, fast, cost-effective and suited for high-throughput protocol for 
determining APOE genotypes by Real Time PCR monitored by SYBR® Green. The 
method is based on differential amplification by allele-specific primers. These primers 
have variations in their 3´-end nucleotides such that are specific for one of the two 
variants in each polymorphic position. By this protocol, we obtained a 100% 
concordance with the APOE genotypes determined by sequencing analysis. The main 
advantages of this method are its relative simplicity and the reduced cost compared to 
other methodologies, such as the TaqMan® and FRET assays.
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3Introduction
Apolipoprotein E (ApoE) is a 34 kDa glycoprotein involved in lipid metabolism 
(Mahley, 1988). The human APOE gene coding for this protein is polymorphic and is 
located on chromosome 19 (Das et al., 1985). There are three common codominant 
alleles2, 3 and 4 that encode three ApoE protein isoforms: E2, E3 and E4. These 
isoforms differ at the amino acid residues 112 and 158. Isoform E2 has cysteine residues 
at both sites, E4 has arginine residues at both sites, while E3, the most common form, 
has a cysteine at position 112 and an arginine at position 158 (Emi et al., 1988). These 
differences have profound effects on the biological functions of ApoE. The lipid-
binding activities of these isoforms are different: E2 and E3 bind preferentially to HDL, 
whereas E4 prefers VLDL (Saito et al., 2003). These biochemical differences may be 
responsible for the association of the isoforms with different pathological processes. 
The isoform E4 is associated with a higher risk for coronary heart and Alzheimer´s 
diseases. In contrast, isoform E2 shows a protective effect against Alzheimer´s disease, 
but it is associated with familial type III hyperlipoproteinemia (Roses et al., 1994). 
Thus, interest in APOE genotyping is high for epidemiological research and it is already 
recognized as valuable information that may help to identify individuals at increased 
risk for cardiovascular disorders, and it may as well be part of future diagnostic or 
predictive algorithms for individuals at risk of developing Alzheimer’s disease. 
Several methods are commonly used for genotyping the three major APOE haplotypes. 
The more frequent method has been traditionally PCR-RFLP (PCR-Restriction 
Fragment Length Polymorphism) analysis (Zivelin et al., 1997). However, it is a time-
consuming and error-prone method, due to possible incomplete restriction enzyme 
4digestion. Capillary electrophoresis (Somsen et al., 2002), PCR plus sequencing or mass 
spectrometry (Srinivasan et al., 1998) are effective methods, but require expensive 
dedicated instrumentation. The ARMS-PCR (Amplification Refractory Mutation 
System-PCR) (Donohoe et al, 1999) and SSP-PCR (Simple Sequence Specific Primer-
PCR) (Pantelidis et al., 2003) methodologies require analysis by agarose gels, thus 
limiting the number of samples that can be examined at a time. The Real Time PCR 
detection by fluorescence melting curves (Papp et al., 2003) is a simple and rapid 
method, but the formation of primer-dimers may complicate the melting curves 
interpretation. The use of FRET (Fluorescent Resonance Energy Transfer) (Rihn et al., 
2009) and TaqMan (Koch et al., 2002) probes in Real Time PCR are very effective, 
although costly methods. 
We describe here an APOE genotyping protocol based in the SSP-PCR methodology 
adapted to Real Time PCR monitored by SYBR® Green. This genotyping method is 
based on differential amplification by allele-specific primers. 
Materials and Methods
Subjects
The study was approved by Alzheimer’s Disease Research Unit. CIEN Foundation-
Reina Sofia Foundation, Institute of Health Carlos III Ethics Committee with the 
adequate understanding and written consent of subjects, family members or legal 
guardians, as appropriate. A total of 280 subjects diagnosed of probable Alzheimer 
according to NINCDS-ADRDA (McKhann et al., 1984) were analyzed. 
5Human genomic DNA isolation
Genomic DNA was extracted from 2 ml of human whole blood by NucleoSpin® Blood 
L kit (Macherey-Nagel) according to the manufacturer’s instructions. 
Oligonucleotide primers design
The primers have been designed from human APOE sequence (NG_007084.2, NCBI 
reference assembly sequence). The forward primers comprise from positions 2886 to 
2903, whereas the reverse primers include from positions 3041 to 3058. Their 3´-end 
nucleotides are located on the polymorphic site, and the specific primers were designed 
to match one of the two variants at the 2903 and 3041 APOE positions (Table 1). 
DNA amplification by Real Time PCR
The primers were combined in three reaction mixtures to yield a predicted amplification 
product of 173 bp: “Reaction ApoE2” (primers ApoE_112C and ApoE_158C), 
“Reaction ApoE3” (primers ApoE_112C and ApoE_158R) and “Reaction ApoE4” 
(primers ApoE_112R and ApoE_158R). Each PCR reaction mixture contained the 
following: 1x Power SYBR® Green PCR Master Mix (Applied Biosystems), 0.3 µM of 
each primer and 50 ng of genomic DNA. Negative controls were performed by using 
the same reaction mixtures without DNA. All the reactions were run in duplicate. The 
PCR amplification protocol was as follows: initial AmpliTaq Gold DNA Polymerase 
activation at 95 ºC for 10 min, followed by 40 cycles with denaturation at 95 ºC for 15 
s, and annealing+extension at 62 ºC for 1 min. Amplification was performed either on a 
StepOne Real Time PCR System (48-well format) (Applied Biosystems), on a 7500 
Real Time PCR System (96-well format) (Applied Biosystems), or on a 7900HT Real-
6Time PCR System (384-well format) (Applied Biosystems) by using the comparative 
CT (CT) method (quantitation experiment setup).
Standard APOE end-point PCR amplification and sequencing
For validation purposes, all samples genotyped by the above-described Real Time PCR 
protocol were contrasted by standard end-point PCR amplification and DNA 
sequencing. In brief, all reactions were carried out with 100 ng of genomic DNA and 1 
unit of Taq DNA Polymerase (Applied Biosystems) in a volume of 25 µl. The final 
concentrations of other reactants were: 1x Taq DNA Polymerase Buffer, 0.1 mM 
dNTPs, 0.5 mM MgCl2, 10% DMSO and 0.1 mM of each primer (forward primer 5´-
TGCCCGGCCTCCTAGCTCCTTC-3´ and reverse primer 5´-
GAGGTGAAGGAGCAGGTGGCGGAG-3´). The PCR cycling conditions were as 
follows: initial denaturation at 94 ºC for 3 min followed by 40 cycles of 94 ºC for 30 s, 
72 ºC for 30 s (decreased 0.4 ºC in each cycle) and 72 ºC for 90 s and a final extension 
at 72 ºC for 7 min. Amplification was performed on a Mastercycler epGradient S 
thermal cycler (Eppendorf). 
An aliquot of 2 µl of the amplicon product from above reaction (687 bp) was used for 
sequencing reactions (BigDye® Terminator v1.1 Cycle Sequencing Kit, Applied 
Biosystems), using the above primers at the same final concentration. The amplified 
fragments were analyzed using an ABI PRISM® 377 Analyzer (Applied Biosystems) 
and Chromas v 2.33 software.
Results and Discussion
7In order to monitor in real time DNA amplification, the double-stranded DNA-
fluorescent dye SYBR® Green was included in all reactions for APOE genotyping.  The 
"cycle threshold", or Ct value (fixed in the exponential phase of the amplification plot 
as the number of PCR cycles necessary to achieve a given level of fluorescence) was 
chosen as the informative Real Time PCR read-out for genotyping results analysis. 
By this method and using the experimental conditions described above in a StepOne 
(48-well format), a 7500 (96-well format), or a 7900HT (384-well format) Real Time 
PCR Systems, we were capable of unequivocally discriminating the different APOE
haplotypes on the basis of their Ct values (Figure 1). The presence/absence of 
haplotypes was determined by differential amplification with the three specific 
amplification setups for 2, 3 or 4 alleles. For example, an APOE 3/4 heterozygous 
yielded Ct values for “Reaction ApoE3” and “Reaction ApoE4” significantly lower 
(Ct5 cycles) compared to “Reaction ApoE2”. Whereas, an APOE 3/3 homozygous 
showed a Ct value for “Reaction ApoE3” significantly lower than the Ct obtained for 
the other two reactions. If the lower Ct values were not in the expected range 
(15Ct25 cycles), the assay was considered failed. In the experimental conditions 
here indicated for genotyping purposes, for the StepOne (48-well format) and the 7500 
(96-well format) Real Time PCR Systems, Ct values lower than 25 indicated a positive 
amplification reaction, whereas Ct values higher than 25 was considered as a negative 
amplification (Figure 1). For the 7900HT Real-Time PCR System the reference Ct 
value was smaller, around 23 (data not shown). These differences appear to be related to 
the sensitivity and the threshold set-up defined for each system. Negative controls did 
not show amplification before cycle 35 in any of the systems. Amplification plots in a 
StepOne Real Time PCR System of the six different APOE haplotypes in the human 
population and negative controls are showed as Supplementary Figure.
8The difference in the Ct values between positive and negative reactions was in all cases 
and systems of at least 5 cycles, which indicates that the specific amplifications are 
more than 32-fold more efficient compared to the non-specific ones.  All the samples 
genotyped by this method showed amplification patterns in perfect concordance with 
the APOE genotypes determined by sequencing analysis. 
In order to explore the versatility and robustness of this genotyping protocol, we studied 
its applicability to lower amounts of DNA material and smaller reaction volumes. Total 
final volumes of the PCR reactions from 10 to 1 l were tested. In our hand, volumes 
down to 2 l were sufficient to distinguish between positive and negative reactions, 
whereas smaller volumes yielded erratic results, likely due to pipetting errors associated 
to our automatic volume dispenser system (data not shown). Different initial DNA 
amounts were tested (from 1 ng up to 50 ng). With decreasing amounts of DNA, we 
observed that the Ct between positive and negative reactions were similar or smaller, 
but always sufficient to differentiate them (data not shown). 
A number of methods have been developed for APOE genotyping. Traditionally, three 
methods have been commonly used, namely PCR followed by DNA sequence analysis, 
PCR followed by RFLP analysis, and PCR followed by Reverse Hybridization. 
Sequence analysis is very reliable, but time consuming and expensive method.  PCR-
RFLP analysis (Zivelin et al., 1997) by mean of digestion of the fragment of the coding 
region of  APOE with HhaI is an inexpensive, but error-prone method, due to possible 
incomplete restriction enzyme digestion or star activity that difficult the interpretation 
of results. Reverse Hybridization, as well as other methods recently developed, 
9including capillary electrophoresis (Somsen et al., 2002), PCR plus sequencing or mass 
spectrometry (Srinivasan et al., 1998), and ARMS-PCR (Donohoe et al, 1999), are 
valuable and convenient techniques for small-scale investigators, but difficult to scale-
up for large number of samples. 
Ponchel et al. (2003) proposed the use of SYBR Green® to perform relative 
quantification of gene rearrangements, gene amplifications and micro gene deletions 
analysis as alternative to the TaqMan® methodology (Koch et al., 2002). The 
advantages were the relative simplicity and the reduced cost of SYBR Green® compared 
to TaqMan® probes. In here, we describe an extension of the use of SYBR Green® for 
APOE genotyping as a fast (approximately 2 h), simple, sensitive, cost-effective and 
reproducible method alternative to the use of TaqMan or FRET probes (Koch et al., 
2002, Rihn et al., 2009). The reduced cost of our protocol is mainly related to the use of 
non-labelled primers instead of expensive labelled probes. Furthermore, because this 
method does not require post-PCR processing or other treatment steps, it represents an 
advantageous option to other SSP-PCR methods (Pantelidis et al., 2003). Thus, our 
method can readily be applied to high-throughput APOE genotyping programs. 
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Legend to Figure 1
Figure 1. Amplification plots (haplotypes vs. Ct) in a StepOne Real Time PCR System 
of the six different APOE haplotypes in the human population and negative controls 
(NC) (2: circles, 3: triangles and 4: squares). 
Legend to Supplementary Figure 
Supplementary Figure. Amplification plots (cycle vs. Rn) in a StepOne Real Time 
PCR System of the six different APOE haplotypes in the human population and 
negative controls (2 in red, 3 in green and 4 in blue). Rn is an indicator of the 
magnitude of the signal generated by the PCR reaction.
Table 1
Table 1. Nucleotide sequence and characteristics of the primers used for APOE
genotyping.
Orientation Nucleotide Sequence 5´-3´ Tm (ºC) % G+C Length (bp)
ApoE_112C Forward CGGACATGGAGGACGTGT 56.3 61 18
ApoE_112R Forward CGGACATGGAGGACGTGC 59.6 67 18
ApoE_158C Reverse CTGGTACACTGCCAGGCA 55.1 61 18
ApoE_158R Reverse CTGGTACACTGCCAGGCG 57.4 67 18
  Polymorphic bases are shown in bold.
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